Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceZephyr Endobronchial Valve System
Generic NameValve, pulmonary
ApplicantPulmonx Corporation
700 Chesapeake Dr.
Redwood City, CA 94063
PMA NumberP180002
Supplement NumberS025
Date Received12/21/2023
Decision Date03/22/2024
Product Code NJK 
Advisory Committee Anesthesiology
Clinical TrialsNCT00129584
Supplement TypeNormal 180 Day Track No User Fee
Supplement Reason Labeling Change - PAS
Expedited Review Granted? No
Combination ProductNo
Predetermined Change Control Plan AuthorizedNo
Approval Order Statement  
Approval of the labeling supplement as required by the PASR letter issued following the PAS final report P180002/R020.
-
-